Perspective Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $337 |
Gross Profit | 337 | |||
EBITDA | -14,384 | -10,680 | -11,438 | -8,584 |
EBIT | -15,053 | -11,250 | -11,784 | -8,846 |
Net Income | -15,122 | -11,704 | -12,284 | -24,675 |
Net Change In Cash | 0 | 0 | 0 | 337 |
Free Cash Flow | -26,347 | -9,917 | 4,776 | -9,097 |
Cash | 226,443 | 252,004 | 142,117 | 9,238 |
Basic Shares | 70,629 | 66,648 | 49,510 | 28,180 |
Annual Financials
| Values in thousands | 2023-12-31 | 2023-06-30 | 2022-12-31 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $1,434 | $7,104 | $7,104 | $10,795 |
Gross Profit | 1,434 | 1,634 | 1,634 | 4,616 |
EBITDA | -39,960 | -14,838 | -14,838 | -7,143 |
EBIT | -40,941 | -15,182 | -15,182 | -7,391 |
Net Income | -46,508 | -14,670 | -14,670 | -7,153 |
Net Change In Cash | 1,434 | 7,104 | 7,104 | 10,795 |
Free Cash Flow | -37,985 | -12,474 | -12,474 | -7,976 |
Cash | 9,238 | 20,993 | 20,993 | 55,890 |
Basic Shares | 26,764 | 142,103 | 142,103 | 141,987 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.21 |
2024-06-30 | -$0.18 |
2024-03-31 | -$0.20 |
2023-12-31 | -$0.09 |
